TITLE

KARARLI KORONER ARTER HASTALARINDA PLATELET FUNCTION ANALYZER-100 VE VERIFY-NOW SİSTEMLERİ KULLANILARAK ÖLÇÜLEN TROMBOSİT İŞLEVLERİNİN KARŞILAŞTIRILMASI

PUB. DATE
January 2011
SOURCE
Nobel Medicus Journal;Jan-Apr2011, Vol. 7 Issue 1, p79
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
60988243

 

Related Articles

  • Platelet Function Testing: Methods of Assessment and Clinical Utility. Mylotte, Darren; Foley, David; Kenny, Dermot // Cardiovascular & Hematological Agents in Medicinal Chemistry;2011, Vol. 9 Issue 1, p14 

    No abstract available.

  • Comparison of Different Methods to Evaluate the Effect of Aspirin on Platelet Function in High-Risk Patients With Ischemic Heart Disease Receiving Dual Antiplatelet Treatment. Rita Paniccia; Emilia Antonucci; Anna Gori; Rossella Marcucci; Serena Poli; Eloisa Romano; Serafina Valente; Cristina Giglioli; Sandra Fedi; Rosanna Abbate; Domenico Prisco // American Journal of Clinical Pathology;Jul2007, Vol. 128 Issue 1, p143 

    Patients with coronary artery disease (CAD) receiving aspirin therapy with a residual platelet reactivity (RPR) may be at increased risk of ischemic vascular events. Point-of-care (POC) methods PFA-100 (Dade-Behring, Marburg, Germany) and VerifyNow (Accumetrics, San Diego, CA) assays have been...

  • Antiplatelet therapy in acute coronary syndromes: beyond aspirin and clopidogrel. Curzen, Nick // Heart;Nov2012, Vol. 98 Issue 22, p1617 

    The author reflects on the use of antiplatelet therapy in acute coronary syndromes (ACS). He informs that although there are evidences for the benefit of using the dual antiplatelet therapy (DAPT) as a medical treatment for ACS, the requirement for DAPT is much stronger. He states that the...

  • Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease. Larsen, Sanne Bøjet; Grove, Erik Lerkevang; Neergaard-Petersen, Søs; Würtz, Morten; Hvas, Anne-Mette; Kristensen, Steen Dalby // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: Aspirin is a cornerstone in management of coronary artery disease (CAD). However, considerable variability in the antiplatelet effect of aspirin has been reported. Aim: To investigate independent determinants of reduced antiplatelet effect of aspirin in stable CAD patients....

  • Old and New Molecular Mechanisms Associated with Platelet Resistance to Antithrombotics. Farré, Antonio J. López; Tamargo, Juan; Mateos-Cáceres, Petra J.; Azcona, Luís; Macaya, Carlos // Pharmaceutical Research;Nov2010, Vol. 27 Issue 11, p2365 

    Current available data show that about 5 to 40% of coronary patients treated with conventional doses of antithrombotic drugs do not display adequate antiplatelet response. Nowadays, aspirin remains the main antiplatelet therapy. However, a significant number of patients show platelet resistance...

  • Point-of-care coagulation testing. Srivastava, Amit; Kelleher, Andrea // Continuing Education in Anaesthesia, Critical Care & Pain;Feb2013, Vol. 13 Issue 1, p12 

    The article focuses on point-of-care coagulation testing (POCCT) which is a rapid specific testing of bodily fluids at the bedside. Since conventional laboratory testing has a long turnaround time, POCCT can offer results within minutes. The authors have listed various POCCT devices that are...

  • Oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention: Balancing efficacy and bleeding risk. Spinler, Sarah A. // American Journal of Health-System Pharmacy;8/1/2010, Vol. 67 Issue 15, pS7 

    Purpose: The benefits and risk of bleeding associated with oral antiplatelet agents used for acute coronary syndrome (ACS) or in patients who have undergone percutaneous coronary intervention (PCI) are discussed. Summary: Over the past decade, significant advances have been made with the use of...

  • The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin. Neergaard-Petersen, Søs; Hvas, Anne-Mette; Grove, Erik Lerkevang; Larsen, Sanne Bøjet; Gregersen, Søren; Kristensen, Steen Dalby // PLoS ONE;7/6/2015, Vol. 10 Issue 7, p1 

    Background: Hyperglycaemia may attenuate the antiplatelet effect of aspirin and thereby increase the risk of cardiovascular events. We investigated the influence of increased haemoglobin A1c (HbA1c) levels on platelet aggregation and turnover in a large cohort of patients with coronary artery...

  • Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease. Larsen, Sanne Bøjet; Grove, Erik Lerkevang; Pareek, Manan; Kristensen, Steen Dalby; Hvas, Anne-Mette // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: Recent studies suggest that the inflammation-associated protein calprotectin may be implicated in the pathogenesis of coronary artery disease (CAD). However, the impact of calprotectin levels on platelet aggregation in CAD patients has never been investigated. Objectives: We...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics